These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 31774449)

  • 1. Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients.
    Bruins FM; Bronckers IMGJ; Groenewoud HMM; van de Kerkhof PCM; de Jong EMGJ; Seyger MMB
    JAMA Dermatol; 2020 Jan; 156(1):72-78. PubMed ID: 31774449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry.
    Oostveen AM; de Jager ME; van de Kerkhof PC; Donders AR; de Jong EM; Seyger MM
    Br J Dermatol; 2012 Jul; 167(1):145-9. PubMed ID: 22616669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry.
    van Geel MJ; Oostveen AM; Hoppenreijs EP; Hendriks JC; van de Kerkhof PC; de Jong EM; Seyger MM
    J Dermatolog Treat; 2015 Oct; 26(5):406-12. PubMed ID: 25485870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
    van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
    Hjalte F; Carlsson KS; Schmitt-Egenolf M
    Br J Dermatol; 2018 Jan; 178(1):245-252. PubMed ID: 28644904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
    Bergstrom KG; Arambula K; Kimball AB
    Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis.
    van Geel MJ; Otero ME; de Jong EM; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2017 Mar; 176(3):771-776. PubMed ID: 27718521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice.
    Kim E; Fischer G
    Australas J Dermatol; 2021 May; 62(2):190-194. PubMed ID: 33586132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis.
    Zidane M; Dressler C; Gaskins M; Nast A
    JAMA Dermatol; 2019 Dec; 155(12):1380-1389. PubMed ID: 31617856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating to Target-A Realistic Goal in Psoriasis?
    Gordon KB; Armstrong AW; Menter MA; Wu JJ
    Semin Cutan Med Surg; 2018 Feb; 37(2S):S44-S47. PubMed ID: 29614137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).
    Koek MB; Buskens E; van Weelden H; Steegmans PH; Bruijnzeel-Koomen CA; Sigurdsson V
    BMJ; 2009 May; 338():b1542. PubMed ID: 19423623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries.
    Raam L; Hartmane I; Valiukevičienė S; Karamova AE; Telegdy E; Botev I; Marina D; Rubant S; Albuquerque T; Constantin MM
    Front Immunol; 2024; 15():1410540. PubMed ID: 38846952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
    Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
    Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fumaric acid esters in recalcitrant pediatric psoriasis: A prospective, daily clinical practice case series.
    van Geel MJ; van de Kerkhof PC; Oostveen AM; de Jong EM; Seyger MM
    J Dermatolog Treat; 2016; 27(3):214-20. PubMed ID: 26452994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals.
    Norlin JM; Nilsson K; Persson U; Schmitt-Egenolf M
    Br J Dermatol; 2020 Apr; 182(4):965-973. PubMed ID: 31325318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis.
    Hebert AA; Bobonich MA; Rodriguez Capriles C; Gallo G; Li L; Somani N; Ridenour T; Wang Y; Edson-Heredia E; Becker EM
    Pediatr Dermatol; 2022 Jan; 39(1):55-60. PubMed ID: 34931346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.